Novotech White Papers
-
Endometrial Cancer — Global Clinical Trial Landscape (2024)
5/17/2024
Enhance your knowledge of the latest advancements in endometrial cancer research with this CRO disease report, featuring new treatments, clinical trials, and future innovations in care.
-
Acute Myeloid Leukaemia: Global Clinical Trial Landscape (2024)
4/8/2024
Learn how the collaboration among researchers, healthcare providers, and pharmaceutical industries holds promise for progress in Acute Myeloid Leukaemia management and care.
-
Precision Oncology Clinical Trials And Statistics 2024
3/12/2024
Delve into the latest advancements in clinical trials, targeted therapies, and the promising future of cancer care, uncovering innovative treatments shaping oncology.
-
Immune Checkpoint Inhibitors Global Clinical Trials Landscape (2023)
11/27/2023
Dive into the forefront of immune checkpoint inhibitors clinical trials with an exploration of the latest trends and key findings.
-
RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific
5/17/2023
Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.
-
Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific
5/9/2023
Unearth key trends in global Phase I trials, including highlights from the top therapeutic areas, indications, and biologic drug types in popular trial regions of Asia Pacific, the United States, and Europe.
-
Capitalize On Regulatory Expertise To Simplify FDA Complexities
5/9/2023
Get an overview of the global approval landscape, pathways to approval, and the importance of a robust clinical development program as made possible with the help of an experienced CRO.
-
Cell & Gene Therapy In The Asia Pacific Clinical Trial Landscape
1/6/2023
Discover how a new class of therapeutics called cell and gene therapies are revolutionizing how diseases are treated and even potentially cured.
-
The Biotech Landscape: Opportunities In China And The Path To USFDA Approval
11/7/2022
In this white paper, learn why western biopharma companies should take advantage of China’s revamped regulatory framework.
-
How Biotechs Are Using DCT Technology To Conduct Trials In The APAC Region
9/22/2022
In this white paper, gain insight into how the Asia Pacific region, with its rapid growth of clinical trials, presents a great opportunity for conducting clinical research and has become the preferred destination for DCTs.